Inuvo Inc
F:CD5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inuvo Inc
F:CD5
|
US |
|
Weimob Inc
F:36W
|
CN |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
|
C
|
Chugai Pharmaceutical Co Ltd
F:CUP
|
JP |
|
C
|
Chugai Pharmaceutical Co Ltd
XMUN:CUP
|
JP |
Shareholder Yield
Current shareholder yield for CD5 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CD5 Price
Inuvo Inc
| Average Annual Return | 29.52% |
| Standard Deviation of Annual Returns | 80.8% |
| Max Drawdown | -93% |
| Market Capitalization | 10.7m EUR |
| Shares Outstanding | 14 610 000 |
| Percentage of Shares Shorted |
N/A
|
CD5 Return Decomposition
Main factors of price return
Stock Splits
CD5's latest stock split occurred on Jun 10, 2025
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, CD5 traded at 0.3425 per share. Afterward, the share price was about 2.974.
The adjusted shares began trading on Jun 10, 2025. This was stock split number 2 in CD5's history, following the previous one in Dec 13, 2010.
